Skip to content

4C Medical Technologies

7 viewers · 30d

Total raised

$71.6M

+$71.6M this year

2 filings since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $71.6M
ROUNDS
2
INVESTORS
80
FOUNDED
N/A
HQ
Maple Grove, MN
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
7

AI overview

Updated

4C Medical Technologies, Inc. is a pioneering medical device company that specializes in developing innovative minimally invasive therapies for structural heart disease. The company's flagship focus is on treating mitral regurgitation (MR), a condition that affects heart function and can lead to severe complications if untreated.

What sets it apart

4C Medical stands out for its commitment to providing treatment options for patients who are currently ineligible for conventional surgical interventions, particularly through the unique design of its AltaValve device.

Funding history

2 rounds
Equity+2Mar 4, 2026
Form D/A
+$71.6M$71.6M total
Equity+2Mar 4, 2025
Form D
+$71.6M total

Products

1 tracked

AltaValve

Medical Device

The AltaValve is an advanced transcatheter mitral valve replacement (TMVR) device designed specifically for patients suffering from mitral regurgitation. This innovative technology addresses the needs of patients who are not suitable candidates for traditional open-heart surgery, providing a crucial alternative therapy to manage their condition effectively.

  • Supra-annular positioning in the left atrium which enhances valve performance
  • Atrial-only fixation that preserves the integrity of the native mitral valve and left ventricle
  • Designed to mitigate complications associated with the complexities of the mitral annulus
  • Flexible delivery options via either transapical or transseptal approaches